Combined chemotherapy and allogeneic human V γ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

.

Source: OncoImmunology - August 27, 2019 Category: Cancer & Oncology Authors: No émie Joalland Laura Lafrance Thibauld Oullier S éverine Marionneau-Lambot Delphine Loussouarn Ulrich Jarry Emmanuel Scotet Source Type: research